U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174180) titled 'The Impact of Wearing the Hijab on Whole-body Heat Loss During Exercise-heat Stress' on Au... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173751) titled 'ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Br... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172542) titled 'High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Mark... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174375) titled 'PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy' on Sep... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173530) titled 'Low Level Light Therapy & Skin Pigmentation' on July 07. Brief Summary: The goal of this ... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174141) titled 'Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Br... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172022) titled 'A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)' on Sept. 11... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172477) titled 'Early Phase Study Using the 'Pivot Extend' System as a Treatment for Patients With Tricusp... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173933) titled 'Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Inje... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173803) titled 'The Progressive Supranuclear Palsy Clinical Trial Platform' on Sept. 03. Brief Summary: T... Read More